8 results
Beta-Blockers in Cirrhosis
 • Pathophysiology
 • Indications:  Prevention of decompensation, Prevention of first variceal bleeding,
in Cirrhosis • Pathophysiology ... gastropathy • Dosing ... BetaBlockers #Cirrhosis #hepatology ... #management #pharmacology ... #indications #dosing
The timing of various hemodynamic and related events during the cardiac cycle

#CardiacCycle #Stages #Systole #Diastole #HeardSounds
related events during ... HeardSounds #Phonogram #Electrocardiogram ... #Pathophysiology ... #Cardiology
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
for appropriate dosing ... Anticoagulation #Management ... #Hematology #Oncology
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
#management #algorithm ... #decisionaid #cardiology ... #hematology #warfarin ... #dosing
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
bleeding risk during ... Anticoagulation #Management ... #Hematology #Oncology
Differentiation Syndrome in APML
Epidemiology:
 • Incidence: common in APL (2-48% depending on the study)
 • Triggers:
ATRA treatment Pathophysiology ... APML #diagnosis #management ... #hematology #oncology
Management of Immune Checkpoint Inhibitor (ICI) Induced Cardiotoxicity
Problem - Immune checkpoint inhibitors (ICIs) are associated with
Management of Immune ... interventions MANAGEMENT ... Monitor and trend electrocardiogram ... Cardiotoxicity #cardiology ... #oncology #management
Management of Anthracyclines and HER2 Antagonist Cardiotoxicity
Anthracyclines cause cardiomyopathy:
 ✖ Reduction in left ventricular ejection fraction
Management of Anthracyclines ... every 3 months during ... Cardiotoxicity #cardiology ... #oncology #pharmacology